BioSpace News Archive

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Seagen Inc. (Nasdaq: SGEN) today announced results from the second cohort (cohort 2) of patients in the pivotal phase 2 single-arm EV-201 trial. In the trial, 52 percent of patients who received PADCEV®

Assertio Holdings, Inc. announced that it closed its previously announced registered direct of common stock at a purchase price of $0.98 per share for gross proceeds of approximately $34.3 million.

Omnicell, Inc., a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the following upcoming investor conferences

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following upcoming virtual investor conferences: The Leerink Virtual 10th Annual Global Healthcare Conference on Wednesday, February 24, 2021 at 1:00 p.m. Eastern Time (ET).

U.S. FDA Approves PANZYGA ® for the Treatment of Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) The first and only FDA-approved intravenous immunoglobulin with two maintenance dosing options for CIDP

A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in people in late stages of one of the most aggressive forms of skin cancer, a new study finds.

Health Canada is warning health care practitioners and patients that unauthorized health products prepared and sold by Galena Pharm Inc.

Fact.MR, a global research & consulting firm, in their latest edition of the report, indicated that the pressure infusion cuffs market will expand at a steady pace.

Fact.MR, a global research & consulting firm, in their latest edition of the report, projected that the linear motion systems market is anticipated to grow at a rapid pace.

Fact.MR, a global research & consulting firm, in their latest edition of the report, projected that the veterinary tables market is projected to expand at a rapid rate.